Leerink Partners Assumes Connect Biopharma Hldgs at Outperform, Announces Price Target of $4
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsInitiationPrice Target
Leerink Partners analyst Will Soghikian assumes Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform rating and announces Price Target of $4.
Leerink Partners analyst Will Soghikian assumes Connect Biopharma Hldgs (NASDAQ:CNTB) with a Outperform rating and announces Price Target of $4.